About NeuroNexus
A full-stack electrophysiology company: neural probes, instruments, and software. Founded in 2004 as a University of Michigan spin-out; founder-led and independently owned since 2019.



We work at the leading edge of neurotechnology — and then make it dependable and available enough that a thousand labs can actually use it.
The people who run NeuroNexus

Daryl R. Kipke
CEO of NeuroNexus and NEL Group, Inc., Founder, and Director of NeuroNexus and NEL Group, Inc.
Ph.D., University of Michigan
Dr. Daryl R. Kipke co-founded NeuroNexus in 2004 to commercialize the silicon probe developed at the University of Michigan, where he was Professor of Biomedical Engineering and Director of the Center for Neural Communication Technology. A serial neurotechnology entrepreneur, he has founded three companies and taken two to acquisition: Neural Intervention Technologies (W.L. Gore) and NeuroNexus (Greatbatch, now Integer, 2012). In 2019 he formed the NEL Group to buy NeuroNexus back, returning it to the independent, founder-led company he leads today, and brought on veteran medtech CEO Tom Hook as partner and fellow director. His research on neural interfaces that communicate with circuits in the brain, spinal cord and autonomic nervous system has produced more than 200 scientific publications and numerous patents. He is a Fellow of the AIMBE.

Rio Vetter
Co-Founder; Chief Operating Officer and Chief Technology Officer
Ph.D., University of Michigan
Since co-founding NeuroNexus in 2004, Dr. Rio Vetter has established himself as an accomplished executive and inspiring leader. Responsible for planning and directing all aspects of NeuroNexus' technical infrastructure, Dr. Vetter's strategic vision blends science, technology, and innovation with the commercial interests of the company. With technical experience in biomedical engineering, neuroscience, electronic systems, and software signal processing algorithms that interface with the nervous/cardiac systems, Dr. Vetter understands the demands of the industry. He orchestrates the objectives of different groups to create a cohesive technology pipeline that starts with research and ends with the manufacturing of innovative, sellable products. Dr. Vetter has a BSE and MSE in Biomedical Engineering from Arizona State University and a Ph.D. in Biomedical Engineering from the University of Michigan. His research has led to the creation of 30+ patents and numerous scientific publications.

Jamille Hetke
Co-Founder; VP for Engineering
M.S., University of Michigan; AIMBE Fellow
One of NeuroNexus's co-founders, Jamille Hetke brings extensive experience in neural probe design, MEMS processing, and advanced packaging to her current role as VP for Engineering. The lead engineer of neural interface projects and chief designer of neural probes, she is actively involved with product development, executive management, and the exploration of new business opportunities. Ms. Hetke's neural probe journey began at the University of Michigan, where she served on the Michigan Probe development team for over two decades. She received a B.S. in Electrical Engineering from Michigan State University and an M.S. in Biomedical Engineering from the University of Michigan. A fellow in the American Institute of Medical and Biological Engineering, Ms. Hetke is recognized as a leader in her field — her work has resulted in over 25 patents and numerous scientific publications.

Priyanka Sehgal
Senior Director of Operations
M.S., Wayne State University
As the Senior Director of Operations at NeuroNexus, Priyanka Sehgal oversees the day-to-day operations of the company, ensuring that everything runs efficiently. Through this role, Ms. Sehgal was responsible for standardizing production and test processes – this has been instrumental in minimizing manufacturing variability. She is actively involved in the development and integration of new technologies. Before her promotion to Director, Ms. Sehgal headed the quality and manufacturing department. Working in this capacity, she designed and implemented the company's quality management system. Ms. Sehgal has a BS in Biomedical Engineering from Maharshi Dayanand University in India and an MS in Biomedical Engineering from Wayne State University, Michigan.
Sales and applications

Jeffrey Adams
Product Engineer
B.S., Michigan State University
While working as part of the sales team, Jeffrey Adams developed a wealth of knowledge about the NeuroNexus product line. Today, he uses these insights in his capacity as a Product Engineer. In addition to supporting sales and marketing initiatives, he heads the Quality Assurance team. Jeffrey received a BS in Engineering from Michigan State University.

Nicolas Alba
Senior Account Executive and Application Scientist

Rosie Rae
Application Scientist and Head of Marketing
Ph.D., Medical University of South Carolina
Dr. Rosie Rae is a tenacious, positive, and driven scientist with expertise in neurophysiology and data analysis. She is passionate about rigorous, ethical science and committed to making complex research accessible and understandable for all audiences. As an Application Scientist at NeuroNexus, Rosie works on the Radiens software development team to optimize features that best serve the scientific community. She also partners directly with users to help them fully leverage the Radiens platform, supporting projects from experimental design through publication submission. Rosie received her B.S. in Molecular Neuroscience from North Central College and her Ph.D. in Biomedical Sciences from the Medical University of South Carolina.
Board of directors, NEL Group, Inc. and NeuroNexus

Thomas J. Hook
Director, NEL Group, Inc. and NeuroNexus
Thomas J. Hook is a Director of NEL Group, Inc. and NeuroNexus. He has led public and private companies in medical technology and precision manufacturing, as President and Chief Executive Officer of Barnes Group; Chief Executive Officer and Director of SaniSure, Inc.; Chief Executive Officer of Q Holding Company; and President, Chief Executive Officer and Chief Operating Officer of Integer (formerly Greatbatch). He earlier held leadership positions at CTI Molecular Imaging and General Electric Medical Systems, chaired the board of HealthNow New York, Inc., and served as a Director of Tactiva Therapeutics, Inc. He began his career as a nuclear engineer in the U.S. Navy, and holds an MBA from Vanderbilt University, a master's degree in chemistry from the State University of New York at Buffalo, and a B.S. in chemistry and mathematics from St. Bonaventure University.
Twenty-two years of neural probes
2004 — Spun out of the University of Michigan
To make the Michigan silicon probe, developed at the university since the 1980s, a product.
Vetter et al., 20042012 — Acquired by Greatbatch (now Integer)
Part of a public medical-technology company for seven years.
2019 — Independent again
The founders, with Tom Hook, formed the NEL Group and bought NeuroNexus back.
2023 — Z-Coat
A site coating with roughly 10× lower impedance.
2024 — SiNAPS active probes
Active probes, with the signals digitized on the probe.
2025 — Vector Array to 128 sites
The Vector Array family extended to 128 recording sites.

Research
Long-standing NIH, NSF, and DARPA support, most of it from NIH
Harvard
Organoid electrophysiology
Mayo Clinic
Intraoperative neuromonitoring
Purdue
Next-generation probes
NeuroNexus at a glance
| Founded | 2004, a University of Michigan spin-out, to make the Michigan silicon probe a product |
|---|---|
| Founders | Daryl R. Kipke, Rio Vetter, and Jamille Hetke |
| Ownership | Wholly owned by NEL Group, Inc. since 2019; founder-led. Daryl R. Kipke and Thomas J. Hook are the directors of both companies |
| Headquarters | 640 Avis Drive, Suite 200, Ann Arbor, Michigan, USA |
| Published record | 5,200+ peer-reviewed publications; 1,000+ labs on six continents |
Careers
To work at NeuroNexus, write to us with your experience and the work you want to do.
Contact
640 Avis Drive, Suite 200, Ann Arbor, MI 48108